Table of Content


1 EXECUTIVE SUMMARY ............................................................................................................. 21

2 STUDY INTRODUCTION .............................................................................................................. 23
2.1 DEFINITION ........................................................................................................................................................... 23
2.2 SCOPE OF THE STUDY ......................................................................................................................................... 23
2.3 RESEARCH OBJECTIVE ........................................................................................................................................ 23
2.4 MARKET STRUCTURE ......................................................................................................................................... 24

3 RESEARCH METHODOLOGY ...................................................................................................... 25
3.1 OVERVIEW ............................................................................................................................................................ 25
3.2 DATA FLOW .......................................................................................................................................................... 27
3.2.1 DATA MINING PROCESS ................................................................................................................................. 27
3.3 PURCHASED DATABASE: .................................................................................................................................... 28
3.4 SECONDARY SOURCES: ...................................................................................................................................... 29
3.4.1 SECONDARY RESEARCH DATA FLOW: ............................................................................................................. 30
3.5 PRIMARY RESEARCH: ......................................................................................................................................... 31
3.5.1 PRIMARY RESEARCH DATA FLOW: ................................................................................................................. 32
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: .......................................................................................... 33
3.6.1 REVENUE ANALYSIS APPROACH ..................................................................................................................... 33
3.7 DATA FORECASTING........................................................................................................................................... 34
3.7.1 DATA FORECASTING TYPE .............................................................................................................................. 34
3.8 DATA MODELING ................................................................................................................................................ 35
3.8.1 MICROECONOMIC FACTOR ANALYSIS: ............................................................................................................ 35
3.8.2 DATA MODELING: ........................................................................................................................................... 36
3.9 TEAMS AND ANALYST CONTRIBUTION ......................................................................................................... 38

4 MARKET DYNAMICS .................................................................................................................... 40
4.1 INTRODUCTION ................................................................................................................................................... 40
4.2 DRIVERS ................................................................................................................................................................. 41
4.2.1 RISING SPORTS-RELATED INJURIES ................................................................................................................ 41
4.2.2 INCREASING NUMBER OF ORTHOPAEDIC SURGERIES ...................................................................................... 41
4.2.3 INCREASING INNOVATIVE SOFT TISSUE REPAIR IMPLANT DEVICES AND SYSTEMS .......................................... 42
4.3 RESTRAINTS .......................................................................................................................................................... 43
4.3.1 SHORTAGES OF SKILLED ORTHOPAEDIC SURGEON ......................................................................................... 43
4.3.2 HIGH COST OF PROCEDURES AND DEVICES ..................................................................................................... 44
4.4 OPPORTUNITY ..................................................................................................................................................... 45
4.4.1 GROWING GERIATRIC POPULATION ................................................................................................................ 45
4.4.2 INCREASING FUNDING AND INVESTMENT ASSOCIATED WITH ORTHOPAEDIC SOFT TISSUE REPAIR .................. 45
4.4.3 GROWING LAUNCH OF SOFT TISSUE REPAIR IMPLANT PRODUCTS................................................................... 46

5 MARKET FACTOR ANALYSIS ...................................................................................................... 47
5.1 PORTER’S FIVE FORCES MODEL ....................................................................................................................... 47
5.1.1 THREAT OF NEW ENTRANTS ........................................................................................................................... 47
5.1.2 BARGAINING POWER OF SUPPLIERS ............................................................................................................... 48
5.1.3 THREAT OF SUBSTITUTES .............................................................................................................................. 48
5.1.4 BARGAINING POWER OF BUYERS .................................................................................................................... 48
5.1.5 INTENSITY OF RIVALRY .................................................................................................................................. 48
5.2 IMPACT OF COVID-19 ON GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET ............................ 49

6 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION ......................... 51
6.1 INTRODUCTION ................................................................................................................................................... 51
6.2 SHOULDER ............................................................................................................................................................ 55
6.2.1 ROTATOR CUFF TEARS ................................................................................................................................... 56
6.2.2 BICEPS TENDONITIS ....................................................................................................................................... 56
6.2.3 OTHERS ......................................................................................................................................................... 57
6.3 KNEE ....................................................................................................................................................................... 57
6.3.1 ACL INJURIES ................................................................................................................................................. 58
6.3.2 MENISCAL TEARS ........................................................................................................................................... 59
6.3.3 COLLATERAL LIGAMENT INJURIES.................................................................................................................. 59
6.3.4 OTHERS ......................................................................................................................................................... 60
6.4 HIP .......................................................................................................................................................................... 60
6.4.1 HIP TENDONITIS............................................................................................................................................. 61
6.4.2 LABRAL TEARS ............................................................................................................................................... 62
6.4.3 OTHERS ......................................................................................................................................................... 62
6.5 FOOT AND ANKLE ............................................................................................................................................... 63
6.5.1 PLANTAR FASCIITIS ....................................................................................................................................... 64
6.5.2 ACHILLES TENDON RUPTURES ........................................................................................................................ 64
6.5.3 TIBIAL TENDON DYSFUNCTION ....................................................................................................................... 65
6.5.4 OTHERS ......................................................................................................................................................... 65

7 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER .............................. 66
7.1 INTRODUCTION ................................................................................................................................................... 66
7.2 HOSPITALS ............................................................................................................................................................ 68
7.3 AMBULATORY SURGICAL CENTERS (ASCS) ................................................................................................... 69
7.4 SPECIALTY ORTHOPAEDIC CLINICS ............................................................................................................... 69

8 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY REGION .................................. 70
8.1 OVERVIEW ............................................................................................................................................................ 70
8.2 NORTH AMERICA ................................................................................................................................................ 72
8.2.1 US.................................................................................................................................................................. 78
8.2.2 CANADA ........................................................................................................................................................ 81
8.3 EUROPE .................................................................................................................................................................. 86
8.3.1 GERMANY ...................................................................................................................................................... 92
8.3.2 FRANCE ......................................................................................................................................................... 96
8.3.3 UK ................................................................................................................................................................. 100
8.3.4 ITALY ............................................................................................................................................................. 103
8.3.5 SPAIN ............................................................................................................................................................ 107
8.3.6 REST OF EUROPE ............................................................................................................................................ 111
8.4 ASIA-PACIFIC ........................................................................................................................................................ 115
8.4.1 CHINA ............................................................................................................................................................ 121
8.4.2 INDIA ............................................................................................................................................................. 124
8.4.3 JAPAN ........................................................................................................................................................... 128
8.4.4 AUSTRALIA .................................................................................................................................................... 132
8.4.5 SOUTH KOREA ................................................................................................................................................ 135
8.4.6 REST OF ASIA-PACIFIC ................................................................................................................................... 140
8.5 REST OF THE WORLD ......................................................................................................................................... 144
8.5.1 MIDDLE EAST AND AFRICA ............................................................................................................................. 150
8.5.2 SOUTH AMERICA ............................................................................................................................................ 154
BY PRODUCT ..................................................................................................................................... 159

9 COMPETITIVE LANDSCAPE ........................................................................................................ 160
9.1 INTRODUCTION ................................................................................................................................................... 160
9.2 MARKET SHARE ANALYSIS, 2023 ...................................................................................................................... 160
9.3 COMPETITOR DASHBOARD .............................................................................................................................. 161
9.4 PUBLIC PLAYERS STOCK SUMMARY ............................................................................................................... 162
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ............................................................................... 162
9.1 KEY DEVELOPMENTS & GROWTH STRATEGIES ........................................................................................... 163
9.1.1 PRODUCT LAUNCH ......................................................................................................................................... 163
9.1.2 PRODUCT APPROVAL ..................................................................................................................................... 163
9.1.3 AQUISITION .................................................................................................................................................... 163
9.1.4 AGREEMENT .................................................................................................................................................. 164
10 COMPANY PROFILES .................................................................................................................. 165
10.1 B. BRAUN SE .......................................................................................................................................................... 165
10.1.1 COMPANY OVERVIEW ..................................................................................................................................... 165
10.1.2 FINANCIAL OVERVIEW .................................................................................................................................... 166
10.1.3 PRODUCTS OFFERED ...................................................................................................................................... 167
10.1.4 KEY DEVELOPMENTS ...................................................................................................................................... 167
10.1.5 SWOT ANALYSIS ............................................................................................................................................ 168
10.1.6 KEY STRATEGIES ............................................................................................................................................ 168
10.2 XIROS LTD. ............................................................................................................................................................ 169
10.2.1 COMPANY OVERVIEW ..................................................................................................................................... 169
10.2.2 FINANCIAL OVERVIEW .................................................................................................................................... 169
10.2.3 PRODUCTS OFFERED ...................................................................................................................................... 169
10.2.4 KEY DEVELOPMENTS ...................................................................................................................................... 170
10.2.5 SWOT ANALYSIS ............................................................................................................................................ 170
10.2.6 KEY STRATEGIES ............................................................................................................................................ 170
10.3 ZIMMER BIOMET ................................................................................................................................................. 171
10.3.1 COMPANY OVERVIEW ..................................................................................................................................... 171
10.3.2 FINANCIAL OVERVIEW .................................................................................................................................... 172
10.3.3 PRODUCT OFFERED ........................................................................................................................................ 172
10.3.4 KEY DEVELOPMENTS ...................................................................................................................................... 173
10.3.5 KEY STRATEGIES ............................................................................................................................................ 173
10.4 CONMED CORPORATION .................................................................................................................................. 174
10.4.1 COMPANY OVERVIEW ..................................................................................................................................... 174
10.4.2 FINANCIAL OVERVIEW .................................................................................................................................... 175
10.4.3 PRODUCTS OFFERED ...................................................................................................................................... 176
10.4.4 KEY DEVELOPMENTS ...................................................................................................................................... 176
10.4.5 KEY STRATEGIES ............................................................................................................................................ 176
10.5 ARTHREX, INC. ..................................................................................................................................................... 177
10.5.1 COMPANY OVERVIEW ..................................................................................................................................... 177
10.5.2 FINANCIAL OVERVIEW .................................................................................................................................... 177
10.5.3 PRODUCTS OFFERED ...................................................................................................................................... 177
10.5.4 KEY DEVELOPMENTS ...................................................................................................................................... 178
10.5.5 KEY STRATEGIES ............................................................................................................................................ 178
10.6 JOHNSON & JOHNSON INC. ................................................................................................................................ 179
10.6.1 COMPANY OVERVIEW ..................................................................................................................................... 179
10.6.2 FINANCIAL OVERVIEW .................................................................................................................................... 180
10.6.3 PRODUCTS OFFERED ...................................................................................................................................... 180
10.6.4 KEY DEVELOPMENTS ...................................................................................................................................... 181
10.6.5 SWOT ANALYSIS ............................................................................................................................................ 181
10.6.6 KEY STRATEGIES ............................................................................................................................................ 182
10.7 INTEGRA LIFESCIENCES HOLDINGS CORPORATION .................................................................................. 183
10.7.1 COMPANY OVERVIEW ..................................................................................................................................... 183
10.7.2 FINANCIAL OVERVIEW .................................................................................................................................... 184
10.7.3 PRODUCTS OFFERED ...................................................................................................................................... 184
10.7.4 KEY DEVELOPMENTS ...................................................................................................................................... 185
10.7.5 SWOT ANALYSIS ............................................................................................................................................ 185
10.7.6 KEY STRATEGIES ............................................................................................................................................ 185
10.8 STRYKER ................................................................................................................................................................ 186
10.8.1 COMPANY OVERVIEW ..................................................................................................................................... 186
10.8.2 FINANCIAL OVERVIEW .................................................................................................................................... 187
10.8.3 PRODUCTS OFFERED ...................................................................................................................................... 187
10.8.4 KEY DEVELOPMENTS ...................................................................................................................................... 188
10.8.5 KEY STRATEGIES ............................................................................................................................................ 188
10.9 SMITH+NEPHEW .................................................................................................................................................. 189
10.9.1 COMPANY OVERVIEW ..................................................................................................................................... 189
10.9.2 FINANCIAL OVERVIEW .................................................................................................................................... 190
10.9.3 PRODUCTS OFFERED ...................................................................................................................................... 190
10.9.4 KEY DEVELOPMENTS ...................................................................................................................................... 191
10.9.5 KEY STRATEGIES ............................................................................................................................................ 191
10.10 BOSTON SCIENTIFIC CORPORATION .............................................................................................................. 192
10.10.1 COMPANY OVERVIEW ..................................................................................................................................... 192
10.10.2 FINANCIAL OVERVIEW .................................................................................................................................... 193
10.10.3 PRODUCTS OFFERED ...................................................................................................................................... 193
10.10.4 KEY DEVELOPMENTS ...................................................................................................................................... 193
10.10.5 KEY STRATEGIES ............................................................................................................................................ 194

11 DATA CITATIONS ......................................................................................................................... 195



List of Figures

LIST OF FIGURES
FIGURE 1 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET: STRUCTURE 24
FIGURE 2 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032) 40
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 43
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032) 44
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET 47
FIGURE 6 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION) 53
FIGURE 7 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE (%), BY APPLICATION, 2023 54
FIGURE 8 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2023 & 2032 (USD MILLION) 67
FIGURE 9 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE (%), BY END USER, 2023 68
FIGURE 10 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY REGION, 2023 & 2032 (USD MILLION) 70
FIGURE 11 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE (%), BY COUNTRY, 2023 71
FIGURE 12 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION) 73
FIGURE 13 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE (%), BY COUNTRY, 2023 74
FIGURE 14 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION) 86
FIGURE 15 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR SHARE (%), BY COUNTRY, 2023 88
FIGURE 16 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION) 115
FIGURE 17 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE, BY COUNTRY, 2023 (%) 117
FIGURE 18 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION) 145
FIGURE 19 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE, BY COUNTRY, 2023 (%) 146
FIGURE 20 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023 160
FIGURE 21 COMPETITOR DASHBOARD: GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET 161
FIGURE 22 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT 166
FIGURE 23 B. BRAUN SE: KEY DEVELOPMENTS 167
FIGURE 24 B. BRAUN SE: SWOT ANALYSIS 168
FIGURE 25 XIROS LTD.: SWOT ANALYSIS 170
FIGURE 26 ZIMMER BIOMET: FINANCIAL OVERVIEW SNAPSHOT 172
FIGURE 27 CONMED CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 175
FIGURE 28 JOHNSON & JOHNSON INC.: FINANCIAL OVERVIEW SNAPSHOT 180
FIGURE 29 JOHNSON & JOHNSON INC.: SWOT ANALYSIS 181
FIGURE 30 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 184
FIGURE 31 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: SWOT ANALYSIS 185
FIGURE 32 STRYKER: FINANCIAL OVERVIEW SNAPSHOT 187
FIGURE 33 SMITH+NEPHEW: FINANCIAL OVERVIEW SNAPSHOT 190
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 193

List of Tables

LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 36
TABLE 2 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 53
TABLE 3 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 54
TABLE 4 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY REGION, 2019–2032 (USD MILLION) 55
TABLE 5 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 55
TABLE 6 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 55
TABLE 7 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR ROTATOR CUFF TEARS, BY REGION, 2019–2032 (USD MILLION) 56
TABLE 8 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR BICEPS TENDONITIS, BY REGION, 2019–2032 (USD MILLION) 56
TABLE 9 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 57
TABLE 10 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY REGION, 2019–2032 (USD MILLION) 57
TABLE 11 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 58
TABLE 12 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 58
TABLE 13 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR ACL INJURIES, BY REGION, 2019–2032 (USD MILLION) 58
TABLE 14 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR MENISCAL TEARS, BY REGION, 2019–2032 (USD MILLION) 59
TABLE 15 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR COLLATERAL LIGAMENT INJURIES, BY REGION, 2019–2032 (USD MILLION) 59
TABLE 16 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 60
TABLE 17 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY REGION, 2019–2032 (USD MILLION) 60
TABLE 18 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 60
TABLE 19 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 61
TABLE 20 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP TENDONITIS, BY REGION, 2019–2032 (USD MILLION) 61
TABLE 21 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR LABRAL TEARS, BY REGION, 2019–2032 (USD MILLION) 62
TABLE 22 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 62
TABLE 23 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY REGION, 2019–2032 (USD MILLION) 63
TABLE 24 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 63
TABLE 25 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 63
TABLE 26 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR PLANTAR FASCIITIS, BY REGION, 2019–2032 (USD MILLION) 64
TABLE 27 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR ACHILLES TENDON RUPTURES, BY REGION, 2019–2032 (USD MILLION) 64
TABLE 28 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR TIBIAL TENDON DYSFUNCTION, BY REGION, 2019–2032 (USD MILLION) 65
TABLE 29 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 65
TABLE 30 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 67
TABLE 31 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HOSPITALS, BY REGION, 2019–2032 (USD MILLION) 68
TABLE 32 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2019–2032 (USD MILLION) 69
TABLE 33 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SPECIALTY ORTHOPAEDIC CLINICS, BY REGION, 2019–2032 (USD MILLION) 69
TABLE 34 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY REGION, 2019-2032 (USD MILLION) 70
TABLE 35 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019-2032 (USD MILLION) 73
TABLE 36 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 73
TABLE 37 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 74
TABLE 38 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019-2032 (USD MILLION) 74
TABLE 39 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019-2032 (USD MILLION) 75
TABLE 40 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019-2032 (USD MILLION) 75
TABLE 41 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOR & ANKLE, BY TYPE, 2019-2032 (USD MILLION) 75
TABLE 42 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 76
TABLE 43 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 76
TABLE 44 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 76
TABLE 45 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 77
TABLE 46 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOR & ANKLE, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 77
TABLE 47 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019-2032 (USD MILLION) 77
TABLE 48 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 78
TABLE 49 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019-2032 (USD MILLION) 78
TABLE 50 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019-2032 (USD MILLION) 78
TABLE 51 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019-2032 (USD MILLION) 79
TABLE 52 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOR & ANKLE, BY TYPE, 2019-2032 (USD MILLION) 79
TABLE 53 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 79
TABLE 54 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 80
TABLE 55 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 80
TABLE 56 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 80
TABLE 57 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOR & ANKLE, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 81
TABLE 58 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019-2032 (USD MILLION) 81
TABLE 59 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 81
TABLE 60 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019-2032 (USD MILLION) 82
TABLE 61 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019-2032 (USD MILLION) 82
TABLE 62 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019-2032 (USD MILLION) 82
TABLE 63 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOR & ANKLE, BY TYPE, 2019-2032 (USD MILLION) 83
TABLE 64 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 83
TABLE 65 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 83
TABLE 66 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 84
TABLE 67 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 84
TABLE 68 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOR & ANKLE, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 84
TABLE 69 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019-2032 (USD MILLION) 85
TABLE 70 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 87
TABLE 71 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 87
TABLE 72 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 88
TABLE 73 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 89
TABLE 74 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 89
TABLE 75 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 89
TABLE 76 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 90
TABLE 77 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 90
TABLE 78 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 90
TABLE 79 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 91
TABLE 80 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 91
TABLE 81 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 91
TABLE 82 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 92
TABLE 83 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 92
TABLE 84 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 92
TABLE 85 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 93
TABLE 86 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 93
TABLE 87 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 93
TABLE 88 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 94
TABLE 89 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 94
TABLE 90 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 94
TABLE 91 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 95
TABLE 92 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 95
TABLE 93 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 96
TABLE 94 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 96
TABLE 95 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 96
TABLE 96 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 97
TABLE 97 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 97
TABLE 98 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 97
TABLE 99 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 98
TABLE 100 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 98
TABLE 101 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 98
TABLE 102 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 99
TABLE 103 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 99
TABLE 104 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 99
TABLE 105 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 100
TABLE 106 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 100
TABLE 107 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 100
TABLE 108 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 101
TABLE 109 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 101
TABLE 110 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 101
TABLE 111 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 102
TABLE 112 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 102
TABLE 113 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 102
TABLE 114 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 103
TABLE 115 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 103
TABLE 116 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 103
TABLE 117 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 104
TABLE 118 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 104
TABLE 119 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 104
TABLE 120 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 105
TABLE 121 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 105
TABLE 122 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 105
TABLE 123 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 106
TABLE 124 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 106
TABLE 125 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 106
TABLE 126 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 107
TABLE 127 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 107
TABLE 128 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 107
TABLE 129 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 108
TABLE 130 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 108
TABLE 131 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 108
TABLE 132 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 109
TABLE 133 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 109
TABLE 134 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 109
TABLE 135 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 110
TABLE 136 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 110
TABLE 137 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 110
TABLE 138 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 111
TABLE 139 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 111
TABLE 140 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 111
TABLE 141 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 112
TABLE 142 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 112
TABLE 143 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 112
TABLE 144 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 113
TABLE 145 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 113
TABLE 146 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 113
TABLE 147 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 114
TABLE 148 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 114
TABLE 149 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 116
TABLE 150 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 116
TABLE 151 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 117
TABLE 152 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 117
TABLE 153 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 118
TABLE 154 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 118
TABLE 155 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 118
TABLE 156 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 119
TABLE 157 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 119
TABLE 158 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 119
TABLE 159 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 120
TABLE 160 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 120
TABLE 161 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 120
TABLE 162 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 121
TABLE 163 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 121
TABLE 164 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 121
TABLE 165 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 122
TABLE 166 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 122
TABLE 167 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 122
TABLE 168 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 123
TABLE 169 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 123
TABLE 170 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 123
TABLE 171 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 124
TABLE 172 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 124
TABLE 173 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 124
TABLE 174 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 125
TABLE 175 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 125
TABLE 176 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 125
TABLE 177 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 126
TABLE 178 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 126
TABLE 179 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 126
TABLE 180 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 127
TABLE 181 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 127
TABLE 182 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 127
TABLE 183 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 128
TABLE 184 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 128
TABLE 185 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 128
TABLE 186 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 129
TABLE 187 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 129
TABLE 188 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 129
TABLE 189 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 130
TABLE 190 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 130
TABLE 191 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 130
TABLE 192 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 131
TABLE 193 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 131
TABLE 194 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 131
TABLE 195 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 132
TABLE 196 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 132
TABLE 197 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 132
TABLE 198 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 133
TABLE 199 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 133
TABLE 200 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 133
TABLE 201 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 134
TABLE 202 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 134
TABLE 203 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 134
TABLE 204 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 135
TABLE 205 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 135
TABLE 206 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 135
TABLE 207 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 136
TABLE 208 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 136
TABLE 209 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 136
TABLE 210 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 137
TABLE 211 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 137
TABLE 212 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 138
TABLE 213 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 138
TABLE 214 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 138
TABLE 215 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 139
TABLE 216 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 139
TABLE 217 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 140
TABLE 218 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 140
TABLE 219 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 140
TABLE 220 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 141
TABLE 221 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 141
TABLE 222 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 141
TABLE 223 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 142
TABLE 224 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 142
TABLE 225 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 142
TABLE 226 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 143
TABLE 227 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 143
TABLE 228 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 145
TABLE 229 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 145
TABLE 230 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 146
TABLE 231 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 146
TABLE 232 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 147
TABLE 233 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 147
TABLE 234 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 147
TABLE 235 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 148
TABLE 236 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 148
TABLE 237 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 149
TABLE 238 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 149
TABLE 239 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 149
TABLE 240 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 150
TABLE 241 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 150
TABLE 242 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 151
TABLE 243 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNE